Phase 2Enrolling by invitationHealthspan endpoint
Tirzepatide and Organ-specific Biological Aging
Tirzepatide and Organ-Specific Biological Aging: A Parallel-Design Feasibility Study Using Proteomic Organ Clocks in a Preventive Brain Health Cohort
- Sponsor
- Atria Research and Global Health Institute (ARGHI) (Academic or other)
- Enrollment
- 22 planned
- Conditions
- Longevity; Preventive Medicine; Biological Ageing
- Interventions
- Tirzepatide
- Ages
- adults, older adults
- Registry
- NCT07906041
Full record on ClinicalTrials.gov
From the registry
The purpose of this study is to evaluate blood-based measures of organ-specific biological age, with a particular focus on the brain, and to investigate their relationship with established clinical indicators of health and their response to treatment with tirzepatide.
Primary outcomes
- Change in Proteomic Brain Age Gap From Baseline to Month 6
History
Study completion expected
Primary completion expected
Last registry update
Registered
Started